How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Anika Therapeutics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
11 clearance records and 7 recall records in the covered releases, across 1 source company names and 7 product codes. Dated history runs from Jul 14, 2005 to Sep 17, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 2 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Integrity Retractable Implant Inserter (6000127)K261869 · MBI | Anika Therapeutics, Inc. | 510(k) | Sep 17, 2026FDA decision date |
| HYALOMATRIXK261311 · QSZ | Anika Therapeutics, Inc. | 510(k) | Sep 2, 2026FDA decision date |
| Integrity ImplantK250997 · OWX | Anika Therapeutics, Inc. | 510(k) | Jun 17, 2025FDA decision date |
| Tactoset® Injectable Bone SubstituteK231968 · MQV | Anika Therapeutics, Inc. | 510(k) | Dec 20, 2023FDA decision date |
| Integrity ImplantK223538 · OWX | Anika Therapeutics, Inc. | 510(k) | Aug 17, 2023FDA decision date |
| Integrity Bone Staple Fixation SystemK223860 · MBI | Anika Therapeutics, Inc. | 510(k) | May 22, 2023FDA decision date |
| Anika Tissue Tack Fixation SystemK222487 · GDW | Anika Therapeutics, Inc. | 510(k) | May 8, 2023FDA decision date |
| TactosetK223915 · MQV | Anika Therapeutics, Inc. | 510(k) | Mar 29, 2023FDA decision date |
| Tactoset Injectable Bone SubstituteK212083 · MQV | Anika Therapeutics, Inc. | 510(k) | Aug 31, 2021FDA decision date |
| SCS 17-01K190956 · MQV | Anika Therapeutics, Inc. | 510(k) | Jan 30, 2020FDA decision date |
| Hyalomatrix, Product nos. 651105, 651103, 651104, and 651301 Product Usage: Hyalomatrix is a bi-layered, sterile, flexible, and comfortable woun…Z-2423-2018 · FRO | Anika Therapeutics, Inc. | Recall | Jul 11, 2018FDA record creation date |
| SCS 17-01K173008 · MQV | Anika Therapeutics, Inc. | 510(k) | Dec 26, 2017FDA decision date |
| Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovi…Z-1382-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
| ShellGell Sodium Hyaluronate 0.8mL Syringe, 12 mg/mL. Sterile. Rx. For intraocular use. Product Number: 1000 Distributed by Cytosol Opthalmics, I…Z-1383-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
| Amvisc Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: 59051Z-1384-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
| Amvisc Sodium Hyaluronate 0.8 mL. Bausch & Lomb, Inc., Rochester, NY Product Numbr: 59081Z-1385-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
| Amvisc Plus Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: 60051Z-1386-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
| Amvisc Plus Sodium Hyaluronate 0.8 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: 60081Z-1387-05 · LZP | Anika Therapeutics, Inc. | Recall | Aug 23, 2005FDA classification date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.